annual EBIT:
-$501.88M-$305.18M(-155.15%)Summary
- As of today (June 17, 2025), DNLI annual earnings before interest & taxes is -$501.88 million, with the most recent change of -$305.18 million (-155.15%) on December 31, 2024.
- During the last 3 years, DNLI annual EBIT has fallen by -$206.13 million (-69.70%).
- DNLI annual EBIT is now -900.21% below its all-time high of $62.72 million, reached on December 31, 2020.
Performance
DNLI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$145.58M-$15.73M(-12.12%)Summary
- As of today (June 17, 2025), DNLI quarterly earnings before interest & taxes is -$145.58 million, with the most recent change of -$15.73 million (-12.12%) on March 31, 2025.
- Over the past year, DNLI quarterly EBIT has dropped by -$13.33 million (-10.08%).
- DNLI quarterly EBIT is now -159.64% below its all-time high of $244.08 million, reached on December 31, 2020.
Performance
DNLI quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$515.21M-$13.33M(-2.66%)Summary
- As of today (June 17, 2025), DNLI TTM earnings before interest & taxes is -$515.21 million, with the most recent change of -$13.33 million (-2.66%) on March 31, 2025.
- Over the past year, DNLI TTM EBIT has dropped by -$307.07 million (-147.53%).
- DNLI TTM EBIT is now -921.46% below its all-time high of $62.72 million, reached on December 31, 2020.
Performance
DNLI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DNLI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -155.2% | -10.1% | -147.5% |
| 3 y3 years | -69.7% | -118.9% | -77.0% |
| 5 y5 years | -135.4% | -142.8% | -123.4% |
DNLI EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -155.2% | at low | -185.4% | at low | -215.8% | at low |
| 5 y | 5-year | -900.2% | at low | -159.6% | at low | -921.5% | at low |
| alltime | all time | -900.2% | at low | -159.6% | at low | -921.5% | at low |
DNLI EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$145.58M(+12.1%) | -$515.21M(+2.7%) |
| Dec 2024 | -$501.88M(+155.2%) | -$129.85M(+5.4%) | -$501.88M(-0.5%) |
| Sep 2024 | - | -$123.19M(+5.7%) | -$504.60M(+1.9%) |
| Jun 2024 | - | -$116.59M(-11.8%) | -$495.21M(+137.9%) |
| Mar 2024 | - | -$132.25M(-0.2%) | -$208.14M(+5.8%) |
| Dec 2023 | -$196.70M(-42.3%) | -$132.57M(+16.5%) | -$196.70M(+16.1%) |
| Sep 2023 | - | -$113.80M(-166.7%) | -$169.47M(+3.9%) |
| Jun 2023 | - | $170.48M(-241.1%) | -$163.16M(-58.7%) |
| Mar 2023 | - | -$120.81M(+14.7%) | -$395.06M(+15.9%) |
| Dec 2022 | -$340.74M(+15.2%) | -$105.34M(-2.0%) | -$340.74M(+9.0%) |
| Sep 2022 | - | -$107.49M(+75.0%) | -$312.52M(+7.5%) |
| Jun 2022 | - | -$61.42M(-7.6%) | -$290.63M(-0.1%) |
| Mar 2022 | - | -$66.50M(-13.8%) | -$291.03M(-1.6%) |
| Dec 2021 | -$295.75M(-571.6%) | -$77.12M(-9.9%) | -$295.75M(-1262.2%) |
| Sep 2021 | - | -$85.59M(+38.5%) | $25.45M(-50.0%) |
| Jun 2021 | - | -$61.82M(-13.2%) | $50.92M(-1.0%) |
| Mar 2021 | - | -$71.22M(-129.2%) | $51.47M(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $62.72M(-129.4%) | $244.08M(-506.0%) | $62.72M(-126.2%) |
| Sep 2020 | - | -$60.12M(-1.9%) | -$239.12M(+4.3%) |
| Jun 2020 | - | -$61.28M(+2.2%) | -$229.16M(-0.6%) |
| Mar 2020 | - | -$59.97M(+3.8%) | -$230.64M(+8.2%) |
| Dec 2019 | -$213.18M(+359.7%) | -$57.76M(+15.2%) | -$213.18M(+164.2%) |
| Sep 2019 | - | -$50.16M(-20.1%) | -$80.70M(+17.8%) |
| Jun 2019 | - | -$62.76M(+47.6%) | -$68.51M(+8.5%) |
| Mar 2019 | - | -$42.51M(-156.9%) | -$63.13M(+36.1%) |
| Dec 2018 | -$46.37M(-48.6%) | $74.72M(-296.8%) | -$46.37M(-67.9%) |
| Sep 2018 | - | -$37.96M(-33.8%) | -$144.63M(+12.2%) |
| Jun 2018 | - | -$57.38M(+122.9%) | -$128.96M(+37.0%) |
| Mar 2018 | - | -$25.75M(+9.4%) | -$94.14M(+4.4%) |
| Dec 2017 | -$90.14M(+3.1%) | -$23.54M(+5.6%) | -$90.14M(+4.4%) |
| Sep 2017 | - | -$22.29M(-1.2%) | -$86.38M(+34.8%) |
| Jun 2017 | - | -$22.57M(+3.8%) | -$64.09M(+54.4%) |
| Mar 2017 | - | -$21.74M(+10.0%) | -$41.52M(+110.0%) |
| Dec 2016 | -$87.43M(+424.2%) | -$19.78M | -$19.78M |
| Dec 2015 | -$16.68M | - | - |
FAQ
- What is Denali Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Denali Therapeutics?
- What is Denali Therapeutics annual EBIT year-on-year change?
- What is Denali Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Denali Therapeutics?
- What is Denali Therapeutics quarterly EBIT year-on-year change?
- What is Denali Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Denali Therapeutics?
- What is Denali Therapeutics TTM EBIT year-on-year change?
What is Denali Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DNLI is -$501.88M
What is the all time high annual EBIT for Denali Therapeutics?
Denali Therapeutics all-time high annual earnings before interest & taxes is $62.72M
What is Denali Therapeutics annual EBIT year-on-year change?
Over the past year, DNLI annual earnings before interest & taxes has changed by -$305.18M (-155.15%)
What is Denali Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DNLI is -$145.58M
What is the all time high quarterly EBIT for Denali Therapeutics?
Denali Therapeutics all-time high quarterly earnings before interest & taxes is $244.08M
What is Denali Therapeutics quarterly EBIT year-on-year change?
Over the past year, DNLI quarterly earnings before interest & taxes has changed by -$13.33M (-10.08%)
What is Denali Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DNLI is -$515.21M
What is the all time high TTM EBIT for Denali Therapeutics?
Denali Therapeutics all-time high TTM earnings before interest & taxes is $62.72M
What is Denali Therapeutics TTM EBIT year-on-year change?
Over the past year, DNLI TTM earnings before interest & taxes has changed by -$307.07M (-147.53%)